XML 34 R32.htm IDEA: XBRL DOCUMENT v2.3.0.15
Segment Information (Tables)
9 Months Ended
Sep. 30, 2011
Segment Information [Abstract] 
Schedule of Segment Reporting Information
Three Months Ended
September 30,
 
Agriculture2
 
Electronics &
Communications
 
Industrial Biosciences3
 
Nutrition & Health4
 
Performance
Chemicals
 
Performance
Coatings
 
Performance
Materials
 
Safety &
Protection
 
Pharm-aceuticals
 
Other
 
Total1
2011
 
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 

 
 

 
 

 
 

Segment sales
 
$
1,368

 
$
841

 
$
293

 
$
844

 
$
2,142

 
$
1,100

 
$
1,745

 
$
1,001

 
$
—

 
$
2

 
$
9,336

Transfers
 
(1
)
 
(4
)
 
(4
)
 
—

 
(58
)
 
—

 
(27
)
 
(4
)
 
—

 
—

 
(98
)
Net sales
 
1,367

 
837

 
289

 
844

 
2,084

 
1,100

 
1,718

 
997

 
—

 
2

 
9,238

PTOI
 
(194
)
5,6 
99

 
(27
)
7,8 
(34
)
7,8 
593

 
72

 
231

 
118

 
70

 
(78
)
7 
850

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2010
 
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 

 
 

 
 

 
 

Segment sales
 
$
967

 
$
703

 
$
—

 
$
304

 
$
1,675

 
$
937

 
$
1,578

 
$
871

 
$
—

 
$
49

 
$
7,084

Transfers
 
—

 
(4
)
 
—

 
—

 
(59
)
 
—

 
(17
)
 
(3
)
 
—

 
—

 
(83
)
Net sales
 
967

 
699

 
—

 
304

 
1,616

 
937

 
1,561

 
868

 
—

 
49

 
7,001

PTOI
 
(191
)
 
126

 
—

 
10

 
292

 
64

 
281

 
134

 
111

 
(64
)
 
763


Nine Months Ended
September 30,
 
Agriculture2
 
Electronics &
Communications
 
Industrial Biosciences3
 
Nutrition & Health4
 
Performance
Chemicals
 
Performance
Coatings
 
Performance
Materials
 
Safety &
Protection
 
Pharm-aceuticals
 
Other
 
Total1
2011
 
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 

 
 

 
 

 
 

Segment sales
 
$
7,869

 
$
2,543

 
$
416

 
$
1,654

 
$
5,934

 
$
3,198

 
$
5,197

 
$
2,991

 
$
—

 
$
39

 
$
29,841

Transfers
 
(1
)
 
(14
)
 
(5
)
 
—

 
(194
)
 
—

 
(81
)
 
(10
)
 
—

 
—

 
(305
)
Net sales
 
7,868

 
2,529

 
411

 
1,654

 
5,740

 
3,198

 
5,116

 
2,981

 
—

 
39

 
29,536

PTOI
 
1,743

5,6 
313

 
(34
)
7,9 
(4
)
7,9 
1,490

 
210

 
773

 
406

 
200

 
(179
)
7 
4,918

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2010
 
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 

 
 

 
 

 
 

Segment sales
 
$
6,641

 
$
1,991

 
$
—

 
$
902

 
$
4,658

 
$
2,801

 
$
4,688

 
$
2,505

 
$
—

 
$
154

 
$
24,340

Transfers
 
(1
)
 
(13
)
 
—

 
—

 
(162
)
 
(1
)
 
(54
)
 
(8
)
 
—

 
—

 
(239
)
Net sales
 
6,640

 
1,978

 
—

 
902

 
4,496

 
2,800

 
4,634

 
2,497

 
—

 
154

 
24,101

PTOI
 
1,478

 
339

 
—

 
44

 
756

 
184

 
772

 
357

 
402

 
(111
)
 
4,221

_______________________________
1                A reconciliation of total segment PTOI to income before income taxes is as follows: 
 
Three Months Ended
 September 30,
 
Nine Months Ended
September 30,
 
2011
 
2010
 
2011
 
2010
Total segment PTOI
$
850

 
$
763

 
$
4,918

 
$
4,221

Net exchange losses, including affiliates
(6
)
 
(160
)
 
(145
)
 
(25
)
Corporate expenses and net interest
(275
)
 
(273
)
 
(913
)
 
(711
)
Income before income taxes
$
569

 
$
330

 
$
3,860

 
$
3,485


 
2 
As of September 30, 2011, Agriculture net assets were $8,058, an increase of $3,131 from $4,927 at December 31, 2010. The increase was primarily due to higher trade receivables due to normal seasonality in the sales and cash collections cycle.
3 
As of September 30, 2011, Industrial Biosciences net assets were $2,596 compared to $0 at December 31, 2010, due to the Danisco acquisition.
4 
As of September 30, 2011, Nutrition & Health net assets were $6,497, an increase of $5,547 from $950 at December 31, 2010. The increase was primarily due to the Danisco acquisition.
5 
Included a $(50) charge recorded in research and development expense in connection with a milestone payment associated with a Pioneer licensing agreement. Since this milestone was reached before regulatory approval was secured by Pioneer, it was charged to research and development expense.
6 
Included a $(75) charge recorded in cost of goods sold and other operating charges associated with the company's process to fairly resolve claims associated with the use of Imprelis®. See Note 11 for additional information.
7 
Included a $(36) restructuring charge impacting the following segments: Industrial Biosciences - $(8); Nutrition & Health - $(10); and Other - $(18). See Note 4 for additional information.
8 
Included a $(132) charge for the fair value step-up of inventories that were acquired as part of the Danisco transaction and sold in the third quarter 2011, which impacted the segments as follows: Industrial Biosciences - $(53) and Nutrition & Health - $(79).
9 
Included second and third quarter 2011 charges totaling $(182) for transaction related costs and the fair value step-up of inventories that were acquired as part of the Danisco transaction, which impacted the segments as follows: Industrial Biosciences - $(70) and Nutrition & Health - $(112).
Schedule of Reconciliation of PTOI
A reconciliation of total segment PTOI to income before income taxes is as follows: 
 
Three Months Ended
 September 30,
 
Nine Months Ended
September 30,
 
2011
 
2010
 
2011
 
2010
Total segment PTOI
$
850

 
$
763

 
$
4,918

 
$
4,221

Net exchange losses, including affiliates
(6
)
 
(160
)
 
(145
)
 
(25
)
Corporate expenses and net interest
(275
)
 
(273
)
 
(913
)
 
(711
)
Income before income taxes
$
569

 
$
330

 
$
3,860

 
$
3,485